Research Article

Platelet-Rich Plasma in the Treatment of Subcutaneous Venous Access Device Scars: A Head-to-Head Patient Survey

Table 2

Results of the primary endpoints (quality-of-life decrease and pain in port area) for the control group and the PRP (Arthrex ACP) group.

QoL decreasePain in port area
Control%ACP%Control%ACP%

None56561578.98085.11995
Very little202015.388.515
Some5515.322.1
More than average6622.1
A lot1313210.522.1

Total100199420
0.3320.787